You searched for metabolic diseases - Page 20 of 64

News and Trends 5 Dec 2022

MaxCyte and Curamys sign cell and gene therapies agreement

…of next-generation cell-based therapeutics and to support cell-based research. Curamys is a South Korean biotechnology company developing cell and gene therapy using cell fusion technology to treat rare intractable diseases,…

December 5, 2022 - 2 minutesmins - By Jim Cornall

Vaccine for honeybees from Dalan Animal Health

In Depth 26 Apr 2023

Vaccine for honeybees: a new hope for American foulbrood disease

…bacterium Paenibacillus larvae, and is one of the most widespread and devastating bee diseases around, wreaking havoc on hives. It gets its name from the foul odor that the larvae…

April 26, 2023 - 9 minutesmins - By Willow Shah-Neville

centogene rare diseases diagnostic ipo nasdaq

News and Trends 4 Nov 2022

Centogene launches rare and neurodegenerative disease Biodata Network

…and neurodegenerative diseases to drive the healthcare of the future – benefitting patients globally.” Biodata Network Bettina Goerner, Centogene’s chief data officer said that 95% of rare diseases currently do…

November 4, 2022 - 3 minutesmins - By Liza Laws

News and Trends 17 Jul 2017

A Brand New Outlook on Induced Pluripotent Stem Cells

…challenges researchers face in the field! Talk of using human stem cells to better understand and even cure diseases has been around for a few decades. The path of stem…

July 17, 2017 - 8 minutesmins - By External Contributor

In Depth 26 Apr 2024

How to overcome clinical trial challenges

…diseases, finding enough people to participate in clinical trials can also be a big challenge. So how can companies overcome clinical trial issues? Sheila Rocchio is the chief marketing officer…

April 26, 2024 - 14 minutesmins - By Jim Cornall

In Depth 30 Nov 2020

Can Anti-Aging Research Keep Us Healthy in the Long Run?

…develops stem cell therapies for age-related diseases such as cardiovascular disease and type 2 diabetes. According to West, treating these diseases with regenerative cell therapy is akin to treating the…

November 30, 2020 - 10 minutesmins - By Jonathan Smith

News and Trends 23 Mar 2023

Gut microbiota to be harnessed as a tool to diagnose diseases

…microbial metabolites are associated with liver fat content. The fact that the gut microbiota associates with many diseases has raised the hope that they could be used for diagnostic purposes….

March 23, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 2 Jul 2024

Swiss biotech going strong in 2024: 18 companies to put on your radar

…age-related diseases, exemplified by Rejuveron Life Sciences’ impressive portfolio in the field. In this article, we show you eighteen biotech companies based in Switzerland worth keeping an eye on. Table…

July 2, 2024 - 20 minutesmins - By Jules Adam

News and Trends 9 Feb 2017

Alma Bio Therapeutics is Aiming to Revolutionize the Treatment of IBD

A new immune modulator to treat Inﬂammatory Bowel Diseases (IBD) is the lead asset in development at Alma Bio Therapeutics. We had the opportunity to meet up with the company’s…

February 9, 2017 - 6 minutesmins - By External Contributor

Weekly Roundup 10 Nov 2023

Korro Bio and Frequency’s merger; Lexeo’s $100 million IPO; Gate Biosciences new class of drugs

…are small molecules that eliminate disease-causing extracellular proteins, which are drivers of many human diseases, ranging from inflammatory conditions to neurodegenerative diseases to several cancers. Gate’s small molecules bind to…

November 10, 2023 - 12 minutesmins - By Willow Shah-Neville

News and Trends 24 Nov 2015

2015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease?

…rarer diseases like progressive supranuclear palsy (PSP). However, generally, all of the Neurodegenerative diseases discussed have protein malformations implicated in neuronal damage, differing by the particular protein and location of…

November 24, 2015 - 9 minutesmins - By Dani Bancroft

News and Trends 28 Nov 2022

Deep Science Ventures and AbbVie to create companies to target inflammatory diseases

Deep Science Ventures (DSV), a London-based venture creator, is teaming up with AbbVie, a global pharmaceutical company, to build one or more new companies targeting immune-mediated inflammatory diseases. Together, the…

November 28, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

MaxCyte and Curamys sign cell and gene therapies agreement

Vaccine for honeybees: a new hope for American foulbrood disease

Centogene launches rare and neurodegenerative disease Biodata Network

A Brand New Outlook on Induced Pluripotent Stem Cells

How to overcome clinical trial challenges

Can Anti-Aging Research Keep Us Healthy in the Long Run?

Gut microbiota to be harnessed as a tool to diagnose diseases

Swiss biotech going strong in 2024: 18 companies to put on your radar

Alma Bio Therapeutics is Aiming to Revolutionize the Treatment of IBD

Korro Bio and Frequency’s merger; Lexeo’s $100 million IPO; Gate Biosciences new class of drugs

2015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease?

Deep Science Ventures and AbbVie to create companies to target inflammatory diseases

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!